CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Apex Bioventures Acquisition Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Apex Bioventures Acquisition Corp
18 Farm Lane
Phone: (650) 344-3029p:650 344-3029 Hillsborough, CA  94010  United States Ticker: PEX PEX
This company ceased filing statements with the SEC on 6/2/2009.
This company is no longer actively traded on any major stock exchange.
Business Summary
Apex Bioventures Acquisition Corporation (Apex) is a blank check company. Apex is a development-stage company formed to acquire, through a merger, capital stock exchange, asset acquisition or other similar business combination, one or more domestic or international assets or an operating business in the healthcare industry. As of December 31, 2008, the Company had not acquired any business operations and it had no operations generating revenue. On March 4, 2009, the Company determined that it would not be able to consummate a business combination on or before June 13, 2009, and approved the dissolution and liquidation of Apex, subject to approval by the Company’s stockholders.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/200912/31/2008YesYes---

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Darrell J.Elliott 62 6/1/2006
President, Chief Operating Officer, Director K. MichaelForrest 65 6/1/2006
Chief Financial Officer, Executive Vice President, Secretary, Director Gary E.Frashier 72 6/1/2006
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Apex Bioventures Acquisition Corp
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corporation
Apex Bioventures Acquisition Corporation
PEX

General Information
Outstanding Shares: 10,781,250 (As of 5/15/2009)
Shareholders: 11
Stock Exchange: AMEX
Federal Tax Id: 204997725


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023